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Aim: Obesity is a risk factor for the development of cardiovascular diseases. Recently
it was shown that overexpression of the Mas-receptor antagonist angiotensin(1-7)
could prevent from diet-induced obesity. However, it remained unclear whether
diet-induced obesity and angiotensin(1-7) overexpression might also have effects on the
cardiovascular system in these rats.
Methods: Twenty three male Sprague Dawley rats were fed with standard chow
(SD+chow, n = 5) or a cafeteria diet (SD+CD, n = 6) for 5 months. To investigate
the effect of angiotensin(1-7) transgenic rats, expressing an angiotensin(1-7)-producing
fusion protein in testis were used. These transgenic rats also received a 5 month’s
feeding period with either chow (TGR+chow, n = 6) or cafeteria diet (TGR+CD, n = 6),
respectively. Hemodynamic measurements (pressure-volume loops) were carried out to
assess cardiac function and blood pressure. Subsequently, hearts were explanted and
investigated according to the Langendorff technique. Furthermore, cardiac remodeling
in these animals was investigated histologically.
Results: After 5 months cafeteria diet feeding rats showed a significantly increased
body weight, which could be prevented in transgenic rats. However, there was no
effect on cardiac performance after cafeteria diet in non-transgenic and transgenic
rats. Moreover, overexpression of angiotensin(1-7) deteriorated cardiac contractility as
indicated by impaired dp/dt. Furthermore, histological analysis revealed that cafeteria diet
led to myocardial fibrosis in both, control and transgenic rats and this was not inhibited
by an overproduction of angiotensin(1-7).
Conclusion: These results indicate that an overexpression of circulating angiotensin(1-7)
prevents a cafeteria diet-induced increase in body weight, but does not affect cardiac
performance in this experimental rat model of obesity. Furthermore, overexpression of
angiotensin(1-7) alone resulted in an impairment of cardiac function.
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INTRODUCTION
According to the World Health Organization obesity is
one of the leading risks for global deaths. Since the mid-
Twentieth century, the prevalence of obesity has increased
substantially and its importance as a main risk factor for
the development of metabolic disorders like diabetes and
metabolic syndrome, and cardiovascular diseases has been
rapidly evolving. One of the major cause of overweight and
obesity is unhealthy diet. Several animal models of obesity have
been described, including diet-induced obesity in rats, which
closely reflects the situation of human obesity (Lutz and Woods,
2012).
In their experimental study Müller-Fielitz et al. demonstrated
that 19 weeks of high-caloric diet in rats resulted in metabolic
syndrome, characterized by obesity, insulin resistance,
hyperphagia, hyperlipidaemia and hypertension (Müller-Fielitz
et al., 2015).
The pathophysiology of obesity and its associated
cardiometabolic alterations are complex and further
investigations are needed to clarify the underlying molecular
mechanisms. However, there is evidence that an association exists
between the renin-angiotensin-aldosterone system (RAAS) and
a number of cardiac and metabolic disorders (Santos et al., 2005,
2008, 2010, 2012; Müller-Fielitz et al., 2015).
In the past years, our understanding of the RAAS has
dramatically changed, since evidence occurred revealing the
existence of a novel arm of this system, the ACE2/angiotensin
peptide 1-7 (Ang(1-7))/Mas receptor axis (Santos et al., 2013a,b).
ACE2 is a transmembrane peptide, converting AngI into
the octapeptide Ang(1-9) and AngII into the heptapeptide
Ang(1-7). As previously described, the newly identified
ACE2/Ang(1-7)/Mas receptor axis seems to be a physiological
antagonist of the conventional ACE/AngII/AT1 receptor
arm (Patel et al., 2014) having vasodilative, antiarrhythmic,
antifibrotic, antithrombotic, antihypertrophic, antiangiogenic
and antiproliferative properties (Passos-Silva et al., 2013; Santos,
2014).
In accordance with these findings, it would be conceivable
that ACE2 and Ang(1-7) may also be involved in diet-induced
obesity. In this regard, Gupte and colleagues observed an increase
in ACE2 concentration in adipose tissue of mice, fed with
high-fat diet (Gupte et al., 2008). Very recently, it could be
shown by members of our group that Ang(1-7) overexpression
in rats could antagonize the diet-induced obesity (Schuchard
et al., 2015). However, it remained unclear, whether these
positive effects are also detectable regarding the cardiovascular
performance.
The initial idea of our study was, that CD may lead
to a cardiac phenotype similar to hypertensive heart disease
with increased tissue fibrosis and that Ang(1-7) overexpression
might antagonize these effects. Since cardiac fibrosis very
early leads to prolongation of the activation process with
prolonged QRS interval in the edpicardial mapping (Dhein
and Hammerath, 2001) we included in vitro Langendorff
experiments on isolated hearts with extracellular multi-electrode
mapping.
MATERIALS AND METHODS
The following experiments were approved by the AnimalWelfare
Committee of the city of Leipzig and have been performed
according to the Guide for the Care and Use of Laboratory
Animals (US National Institute of Health (publication No. 85–
23, revised 1996). Body parameters as well as clinical parameters
were determined under non-blinded conditions. In contrast, for
epicardial mapping and histological analysis investigator was
blinded.
Animal Model
All animals of our study were previously included into
another study. In this study the working group of Prof. Dr.
Raasch, Institute of Experimental and Clinical Pharmacology
and Toxicology of the University of Lübeck investigated the
effect of cafeteria diet (CD) and an overproduction of Ang(1-
7) on metabolic parameters like body weight, food intake
and insulin sensitivity at day 147 or 154 as described in the
manuscript of Schuchard et al. (2015). For measurement of
the insulin sensitivity an insulin tolerance test was carried out:
0.6 international units per kg body weight were administered
subcutaneously and glucose levels were determined in blood
samples during a 360min period. Total energy intake was also
assessed.
After finishing their measurements animals were delivered on
day 160 to the heart center for cardiac investigation.
Thirty four weeks old male Sprague Dawley (SD) rats (Saint
Berthevin, Cedex, France) (n = 23), obtained from Prof. Dr.
Raasch, were investigated. Male transgenic rats (TGR, n = 12),
overexpressing Ang(1-7) were generated by Prof. Dr. Michael
Bader (Max-Delbrück-Center for Molecular Medicine in Berlin).
In this transgenic rat model, an Ang(1-7)-producing fusion
protein (TGR(A1-7)3292) was expressed in the testis of the rats.
This fusion protein is then cleaved in the testis tissue resulting
in an about 4.5-fold increase in testicular Ang(1-7) and a 2.5-
fold increase in circulating Ang(1-7) (Schuchard et al., 2015).
In detail, the generation of these transgenic rats was described
previously by Santos et al. (2004).
A total of 23 rats were maintained in pairs and under
controlled conditions at room temperature and with a 12:12 h
light/dark cycle. Water was provided ad libitum.
Feeding
At 12 weeks of age rats were divided into four groups depending
on their genetic background and the 5month’s feeding procedure.
The first group were wild type (WT) rats only fed on standard
laboratory diet (SD+chow, n = 5). The second group
included WT rats, which had free access to standard chow
and cafeteria diet (CD) (SD+CD, n = 6). As previously
described, CD consisted of commercial chocolate and cookies
(62% carbohydrates, 25% fat, 6% protein, 2% fiber). Rats received
only one kind of sweet per day (Müller-Fielitz et al., 2015;
Schuchard et al., 2015). Furthermore, chocolate and cookie bars
were changed daily in a regular manner (Müller-Fielitz et al.,
2015; Schuchard et al., 2015). The third group were transgenic
(TGR) rats, receiving standard chow food (TGR+chow, n = 6).
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The transgenic rats of the fourth group could also freely choose
between chow and CD (TGR+CD, n = 6).
Study Protocol
After 5 month of feeding rats were weighted (once per rat)
and submitted to the final experiment. Therefore, the rats
were anesthetized by intramuscular injection with a mixture of
fentanyl (0.005mg/kg body weight), midazolam (2mg/kg body
weight) and medetomidin (0.15mg/kg body weight). Afterwards,
they were intubated and anesthesia was maintained using
isoflurane (0.8–1%). To avoid blood clotting heparin (1000 E/kg
body weight) was injected into the tail vein.
Echocardiography
After rats were anesthetized transthoracic echocardiography was
performed using a GE Vivid I ultrasound system (ultrasonic
probe 3S, GE Healthcare, Munich, Germany). The left ventricle
was examined in the parasternal short axis view and fractional
shortening as well as ejection fraction were calculated to assess
left ventricular function. A total of five measurements per rat
were carried out to obtain mean EF and FS, respectively.
Pressure-Volume-Loops
For hemodynamic measurements a 4-segment Millar catheter
(SPR 869, Millar instruments, Houston, USA) was inserted
into the left ventricle of the anesthetized rats via the left
carotid artery. The pressure-volume-relationship of the left
ventricle was recorded under baseline conditions and during
stimulation of the beta-adrenoceptor by dobutamine (single
dose of 0.2mg/kg body weight). The following hemodynamic
parameters were measured using a signal amplifier (MPVS Ultra,
Millar instruments, Houston, USA) and for data acquisition the
Power Lab and Lab Chart Software (Föhr Medical Instruments,
Seeheim, Germany) was used: heart rate, maximal enddiastolic
(LVEDP) and endsystolic (LVESP) left ventricular pressure,
maximal systolic contraction velocity (dp/dt(max)) and maximal
diastolic relaxation velocity (dp/dt(min)). To determine arterial
blood pressure the maximum (systolic) and minimum (diastolic)
pressure in the left carotid artery was measured under baseline
conditions using the Millar catheter before inserting the catheter
into the chamber of the left ventricle. A total of five pressure-
volume-loops per rat were recorded to assess hemodynamic
parameters.
After completion of hemodynamic recordings the thorax
was opened by thoracotomy and hearts were removed for
further experiments. Subsequently, the weight of the hearts was
determined (once per rat).
Epicardial Mapping
The excised rat hearts were prepared according to the
Langendorff-technique as described in detail previously by Dhein
et al. (1993).
At a constant pressure of 75 cmH2O and a temperature
of 37◦C hearts were perfused with Tyrode’s solution (Na+
161.02mmol L−1, K+ 5.36mmol L−1, Ca2+ 1.8mmol L−1, Mg2+
1.05mmol L−1, Cl− 147.86mmol L−1, HCO−3 23.8mmol L
−1,
PO2−4 , and glucose 11.1mmol L
−1; pH 7.4), equilibrated with
95% O2 and 5% CO2. To measure the left ventricular pressure
(LVP) a balloon was fit into the left ventricle via the left atrium.
Furthermore, the coronary flow (CF g−1 heart weight) and
the basic cycle length (BCL) were monitored. To evaluate the
electrical excitation epicardial potential mapping was performed
according to Dhein et al. (1993). A total of 256 AgCl electrodes
in four polyester plates (each 8 × 8 electrodes with an inter-
electrode distance of 1mm) were attached to the surface of
the rat hearts in an elastic manner, allowing the electrodes to
follow themovement of the heart. Using a computer-assisted 256-
channel mapping system (HAL4, Ing. Büro P. Rutten, Hamburg,
Germany) 256 unipolar extracellular potentials were recorded
simultaneously. According to Durrer and van der Tweel the
activation time points at each electrode were defined as the time
point of the most negative intrinsic deflection (t(dU/dtmin))
(Durrer and van der Tweel, 1954). Moreover, peak to peak
amplitude of the extracellular potentials (PTP), PQ and QRS
duration, as well as total activation time (TAT) were assessed.
TAT was defined as the time between the activation of the
first and the last electrode in a certain heart region. Epicardial
mapping experiments were performed once per rat.
Histological Analysis
For histological analysis hearts were fixed in 4% buffered
formaldehyde solution for 1 week and stored in 70% ethanol
until further processing. Afterwards, hearts were embedded
in paraffin, 2µm thick sections were cut and prepared for
histological analysis. Investigations of the histological stained
slides were performed using a Zeiss Axiolab microscope and the
software AxioVision 4.6 (Zeiss, Jena, Germany).
Conventional hematoxylin-eosin-staining (HE) were carried
out to determine the capillary to muscle fiber ratio. 10 visual
fields of fasciated myocardial cells per rat were acquired at ×400
magnification and analyzed using the image processing program
ImageJ 1.47 (Java) and the ratio of capillary to muscle fiber
was determined. Furthermore, 2µm sections of the paraffin
embedded rat hearts were stained with Picrosirius red to evaluate
cardiac fibrosis. Using the image analysis program SigmaScan
Pro 5 (Jandel Scientific, Erkrath, Germany) 10 visual fields
per rat were photographed at ×200 magnification and assessed
concerning the percentage of total collagen content within the
myocardium.
For histological analysis a total of 50 (SD+chow) and 60
(SD+CD; TGR+chow; TGR+CD), respectively, visual fields of
myocardium were investigated.
Measurement of the Femur Length
To further examine the influence of CD feeding and
overexpression of Ang(1-7) on body parameters of the rats,
the femur was prepared and the length was measured (once per
rat).
Statistical Analysis
All data are expressed as means ± SEM of n experiments.
Statistical analyses were performed using Analysis of Variance
(ANOVA), if the assumption of normal distribution and equal
variance between the groups are met. If ANOVA indicated
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significance subsequently pairwise comparison by Tukey’s post-
hoc test was done. In case of non-normal distribution and/or
the variance was not similar between the groups Kruskal-Wallis
test was carried out followed by pairwise comparison using the
Dwass-Steele-Chritchlow-Fligner. Significance has been accepted
at a significance level of p < 0.05. Analyses were performed using
Systat 11.0 for Windows software (Jandel Scientific, Erkrath,
Germany).
RESULTS
After a 5 month feeding period the body weight, heart weight
and femur length of rats were evaluated (Figure 1). The body
weight ofWT rats, which received chow and CDwas significantly
elevated compared to WT rats, only fed with chow (Figure 1A).
The body weight of TGR+chow rats was significantly lower
than that of SD+chow rats. After 5 month of CD feeding TGR
rats showed significantly reduced body weight in comparison
to the SD+CD group, exhibiting nearly the same body weight
like TGR+chow rats. Furthermore, CD feeding of WT rats
led to a significant increase in heart weight to femur length
ratio compared to SD+chow rats (Figure 1B). In contrast,
overexpression of Ang(1-7) inhibited the CD-mediated increase
of heart weight to femur length ratio. In addition, CD of WT rats
resulted in a significant increase in body weight to femur length
ratio compared to SD+chow rats (Figure 1C). Transgenic rats,
regardless of feeding, showed significantly decreased body weight
to femur length ratio in comparison to SD+chow and SD+CD
rats, respectively.
An overexpression of Ang(1-7) clearly prevents from an
increase in body weight after CD.
Hemodynamic Measurements
Echocardiographic measurements revealed that there was no
difference in ejection fraction and fractional shortening of the
left ventricle between the four groups (Table S1). Moreover, no
change of systolic and diastolic blood pressure has been observed
after CD feeding in WT rats (Figures 2A,B). Overexpression
of Ang(1-7) alone led to a significantly reduced systolic and
diastolic blood pressure compared to SD+chow rats. In contrast,
overexpression of Ang(1-7) in combination with CD caused
significantly elevated systolic and diastolic blood pressures
compared to transgenic rats, receiving only chow (Figures 2A,B).
To further analyse left ventricular performance pressure-
volume-relationship was investigated. Thereby, pressure-
volume-loops were recorded under baseline conditions as
well as after stimulation with the beta-adrenoceptor agonist
dobutamine to assess beta-adrenergic responsiveness of rat
hearts. There was no difference in heart rate under baseline
conditions as well as after dobutamine stimulation between the
several rat groups (Table S1). Moreover, in WT rats there was no
change in endsystolic and enddiastolic left ventricular pressure
after CD (Table S1). TGR rats, only fed with chow showed
slightly but not significantly reduced baseline endsystolic and
enddiastolic left ventricular pressure compared to SD+chow
rats. Additionally, dobutamine response regarding endsystolic
and enddiastolic left ventricular pressure was also decreased
FIGURE 1 | Body parameters of male wild type Sprague Dawley rats
(SD) and transgenic rats (TGR), overexpressing Ang(1-7) after a 5
month feeding period with either standard chow alone or
simultaneously chow and cafeteria diet (CD). CD increased body weight
(A), altered heart weight to femur length ratio (B) and elevated body weight to
femur length ratio (C) in wild type SD rats. In transgenic rats an overexpression
of Ang(1-7) prevented the CD-induced effects on body parameters. Data
expressed as means ± SEM of n experiments. Significant changes vs. chow
rats are indicated by a hash key (p < 0.05), significant changes between
groups are indicated by an asterisk (p < 0.05). Body weight was analyzed by
Kruskal-Wallis followed by pairwise comparison using the
Dwass-Steele-Chritchlow-Fligner. Heart weight to femur length ratio and body
weight to femur length ratio were analyzed by ANOVA followed by pairwise
comparison using Tukey HSD.
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FIGURE 2 | Hemodynamic measurements of the left ventricle of male wild type Sprague Dawley rats (SD) and transgenic rats (TGR), overexpressing
Ang(1-7) after a 5 month feeding period with either standard chow alone or simultaneously chow and cafeteria diet (CD). (A,B) Recordings of systolic
(Continued)
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FIGURE 2 | Continued
and diastolic blood pressure were carried out under baseline conditions, using a Millar catheter, which was inserted into the left carotid artery. TGR+chow rats
showed a significantly impaired systolic and diastolic blood pressure in comparison to SD+chow rats. TGR+CD rats exhibited a significant increase in systolic and
diastolic blood pressure compared to TGR+chow rats. Significant changes vs. chow rats are indicated by a hash key (p < 0.05), significant changes between groups
are indicated by an asterisk (p < 0.05). (C) Evaluation of dp/dt has been carried out under baseline conditions and under venous injection of dobutamine, using a
Millar catheter, which was inserted into the left ventricle via the left carotid artery. CD had no effect on dp/dt(max) and dp/dt(min) in wild type SD rats. TGR+chow rats
showed an impairment of dp/dt(max) and dp/dt(min) under baseline conditions and after dobutamine stimulation compared to SD+chow rats. CD in TGR rats resulted
in an increase in dp/dt(max) under baseline and after dobutamine stimulation as well as baseline dp/dt(min) compared to TGR+chow rats, whereas dobutamine
response regarding dp/dt(min) was unaltered. Significant changes vs. dobutamine stimulation are indicated by a hash key (p < 0.05), significant changes between
groups are indicated by an asterisk (p < 0.05). Data are expressed as means ± SEM of n experiments. Hemodynamic parameters were analyzed by Kruskal-Wallis
followed by pairwise comparison using the Dwass-Steele-Chritchlow-Fligner.
(non-significant) in TGR+chow rats in comparison to SD+chow
rats. However, CD feeding of TGR rats resulted in significantly
elevated endsystolic and enddiastolic left ventricular pressure
under baseline conditions compared to TGR+chow rats.
Furthermore, the dobutamine effect regarding enddiastolic left
ventricular pressure was also increased in the TGR+CD group in
comparison to TGR+chow, whereas endsystolic left ventricular
pressure after dobutamine stimulation was not different between
these two groups. TGR+CD rats also exhibited a significantly
elevated enddiastolic left ventricular pressure under baseline
conditions and after dobutamine stimulation compared to
SD+CD rats.
No changes in maximal systolic left ventricular contraction
velocity (dp/dt(max)) and maximal diastolic left ventricular
relaxation velocity (dp/dt(min)) has been observed after CD in
WT rats (Figure 2C). In contrast, TGR+chow rats exhibited
a significantly impaired baseline dp/dt(max) and dp/dt(min)
compared to SD+chow rats (Figure 2C). The dobutamine effect
regarding dp/dt(max) and dp/dt(min) was also significantly
reduced in the TGR+chow group compared to SD+chow
rats. Again, CD led to enhanced dp/dt(max) and dp/dt(min)
values under baseline conditions in TGR rats in comparison
to TGR+chow animals, whereas the dobutamine response
regarding dp/dt(min) was not different between TGR+chow and
TGR+CD rats.
Taken together, in contrast to what was expected,
hemodynamic measurements revealed that TGR+chow rats
showed impairment in left ventricular function in comparison
to SD+chow. In addition, CD caused no impairment in cardiac
contractility in both, WT and transgenic rats. However, there
was an increase in systolic and diastolic blood pressure by CD,
but only in transgenic rats as compared to TGR-chow, but not
significantly exceeding SD-rats (Figures 2A,B).
Epicardial Mapping
To investigate the electrical activity of the heart surface
epicardial mapping analysis of the isolated-perfused rat hearts
were performed (Figure 3; Table S2). Tendentially but not
significantly, there was a rise in coronary flow to heart weight
ratio in WT rats after CD compared to WT rats, which were
fed with chow (Figure 3A). Although, overexpression of Ang(1-
7) alone caused a minor decrease in coronary flow to heart
weight ratio compared to SD+chow rats, this difference was
not statistically significant. Nevertheless, an overproduction
of Ang(1-7) after CD significantly abolished the CD-induced
increase in coronary flow to heart weight ratio. Results of the
256 recorded epicardial electrocardiograms illustrated that there
was no alteration in PQ duration of WT rats, fed with CD.
PQ duration of TGR+chow rats remained also unchanged in
comparison to SD+chow rats. On the contrary, TGR+CD rats
showed a significantly prolonged PQ duration than SD+CD
rats, indicating a delayed atrioventricular conduction time
(Figure 3B).
Other evaluated parameters such as left ventricular pressure,
QRS duration, basic cycle length, total activation time and peak
to peak amplitude remained unchanged in all four rat groups
(Table S2).
Histological Analysis
Histological analysis revealed that rats, fed with CD for 5months,
showed obvious fibrosis in the myocardium, although there
was no difference between WT and transgenic rats (Figure 4).
Overexpression of Ang(1-7) alone had no effect on myocardial
fibrosis. Furthermore, under CD feeding a significant decrease
of capillary to muscle fiber ratio could be observed in WT rats
(Figure 5). TGR+chow rats exhibited also a reduced capillary
to muscle fiber ratio as compared to SD+chow rats (non-
significant). In contrast, CD feeding of rats, overexpressing
Ang(1-7), resulted in a significant increase in capillary to muscle
fiber ratio compared to TGR+chow rats as well as in comparison
to SD+CD rats.
In summary, CD caused fibrosis, which could not be
prevented by an overproduction of Ang(1-7). Furthermore, CD
led to a decrease in capillary to muscle fiber ratio, whereas an
overexpression of Ang(1-7) could inhibit this CD-mediated effect
and even led to an increase in capillary to muscle fiber ratio.
DISCUSSION
Obesity is a major global health problem, which becomes
more and more important, especially because it is a main risk
factor for the development of several cardiometabolic disorders.
Thus, the finding, that Ang(1-7) could antagonize diet-induced
obesity (Schuchard et al., 2015) was highly interesting, and
needed an evaluation whether this effect could be extended to
cardiovascular disorders.
The heart is one of the main targets for the novel members
of RAAS, the ACE2/Ang(1-7)/Mas receptor axis, but there are
controversial results regarding their functional cardiac role. The
major findings of our current work are as follows.
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FIGURE 3 | Epicardial mapping analysis of isolated-perfused hearts of
male wild type Sprague Dawley rats (SD) and transgenic rats (TGR),
overexpressing Ang(1-7) after a 5 month feeding period with either
standard chow alone or simultaneously chow and cafeteria diet (CD).
Isolated-perfused rat hearts were prepared according to
Langendorff-technique. Epicardial mapping was performed as previously
described by Dhein et al. (1993). (A) Coronary flow was related to heart weight
and is given as coronary flow to heart weight ratio. TGR+CD rats showed
significantly reduced coronary flow to heart weight ratio compared to SD+CD
rats. (B) Furthermore, PQ duration of rat hearts was measured. CD in
combination with an overexpression of Ang(1-7) led to a significant
prolongation of PQ duration in comparison to SD+CD rats. Data expressed as
means ± SEM of n experiments. Significant changes between groups are
indicated by an asterisk (p < 0.05). Coronary flow to heart weight ratio and PQ
duration were analyzed by Kruskal-Wallis followed by pairwise comparison
using the Dwass-Steele-Chritchlow-Fligner.
(1) CD in form of a high sugar diet caused elevated body
weight of rats, which was prevented by an overexpression of
Ang(1-7). In a previous study Schuchard et al. investigated
the same animals, which we inspected in our study. They
focused on the effect of CD and overexpressed Ang(1-7)
on metabolic parameters of these rats. They could show
that the antiobese effect of overexpressed Ang(1-7) was
associated with a reduced energy intake but an increased
energy expenditure (Schuchard et al., 2015). Furthermore,
FIGURE 4 | Total collagen content in the myocardium of male wild type
Sprague Dawley rats (SD) and transgenic rats (TGR), overexpressing
Ang(1-7) after a 5 month feeding period with either standard chow
alone or simultaneously chow and cafeteria diet (CD). (A) Original
histological images of 2µm sections of rat myocardium stained with Picrosirius
Red. (B) Quantitative analysis of total collagen content. CD caused myocardial
fibrosis in both WT and transgenic rats, without differences between these
groups. Data are expressed as means ± SEM of n experiments. Significant
changes vs. chow rats are indicated by a hash key (p < 0.05). Total collagen
content was analyzed by ANOVA followed by pairwise comparison using
Tukey HSD.
they observed leptin and insulin resistance, and obesity in
SD rats, fed with CD, but not in TGR rats, also received CD
(Schuchard et al., 2015).
(2) CD had no effect on cardiac performance. However,
an overexpression of Ang(1-7) alone resulted in an
impairment of hemodynamic parameters, whereas Ang(1-
7) overexpression in combination with CD had no obvious
effect on cardiac function.
(3) CD induced moderate increase in coronary flow to heart
weight ratio, whereas transgenic rats, fed with CD, showed
a decrease in coronary flow to heart weight ratio.
(4) Prolongation of the PQ duration, which represents
atrioventricular conduction time, could be observed in rats,
overexpressing Ang(1-7) and receiving CD.
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FIGURE 5 | Capillary to muscle fiber ratio in the myocardium of male
wild type Sprague Dawley rats (SD) and transgenic rats (TGR),
overexpressing Ang(1-7) after a 5 month feeding period with either
standard chow alone or simultaneously chow and cafeteria diet (CD).
CD led to a decrease in capillary to muscle fiber ratio in WT rats, whereas CD
in transgenic rats resulted in an increase in capillary to muscle fiber ratio. Data
are expressed as means±SEM of n experiments. Significant changes vs.
chow rats are indicated by a hash key (p < 0.05), significant changes between
groups are indicated by an asterisk (p < 0.05). Capillary to muscle fiber ration
was analyzed by ANOVA followed by pairwise comparison using Tukey HSD.
(5) CD caused myocardial fibrosis, regardless of the genetic
background of the rats.
(6) CD led to a significantly reduced capillary to muscle fiber
ratio. Interestingly, this CD-mediated decrease could be
prevented by an overexpression of Ang(1-7).
In conclusion, there was no deteriorating effect of a 5 months
CD feeding period on heart function compared to standard chow
diet. Furthermore, in this model an overexpression of Ang(1-
7) had no beneficial effect on heart function in both, chow and
CD fed rats. On the contrary, overexpression of Ang(1-7) alone
resulted in an impairment of cardiac performance. However,
body weight, coronary flow to heart weight ratio and capillary
to muscle fiber ratio were affected by CD and this CD-mediated
effect regarding these parameters could be inhibited by Ang(1-7).
First, the lack of cardiovascular effect of CD needs discussion:
Others have described the development of hypertension
following CD (e.g., Coatmellec-Taglioni et al., 2000; Muntzel
et al., 2012; Steiner et al., 2013) and attributed this to increased
sympathetic activity (Muntzel et al., 2012) or to the RAAS system
(Miesel et al., 2010; Müller-Fielitz et al., 2014). Regarding the
cafeteria diet, the authors used 2–20 weeks protocols, so that our
protocol seems comparable. However, in contrast to the other
authors, we assessed blood pressure in general anesthesia via a
Millar catheter, while others used the cuff and collar method. It
might be, that due to the hypotensive effects of narcotics our
data did not reveal hypertension. Another explanation could
be, that the composition of the diet might vary from group to
group. Maybe that a longer time of CD-in the composition used
by us-is needed to allow the cardiovascular effects to develop.
Some of the authors (Miesel et al., 2010) used spontaneously
hypertensive rats, which also may exhibit some differences in
the blood pressure response. However, our data clearly show
that there are only very moderate insignificant changes in the
hearts performance, the isolated hearts characteristic, while there
is a profibrotic effect in cardiac histology, which however, does
not seem to be transduced to the functional level. Thus, from
our data, we assume that the CD model is an useful obesity
model, but does only partially represent metabolic syndrome as
the cardiovascular effects are very small.
In accordance with the results of our work, several studies also
reported deleterious effects of the ACE2/Ang(1-7)/Mas receptor
axis on the heart. Thus, Donoghue et al. demonstrated that a
cardiac overexpression of ACE2 in transgenic mice led to sudden
death due to conduction and rhythm disturbances, associated
with ventricular arrhythmias (Donoghue et al., 2003). They
further revealed that AV block is a main risk factor for the
development of ventricular ectopy and sudden cardiac death
in the ACE2 transgenic mice. According to our initial idea,
we expected CD-induced cardiac fibrosis leading to slowing of
ventricular conduction evident from increased TAT, QRS, and
reduced PTP-amplitude. Although cardiac fibrosis was induced
by CD (Figure 4B) this did not reach functional relevance., since
TAT, QRS, and PTP were unaltered in CD rats (Table S2). In
comparison to previous studies on aged rabbits, the degree of
fibrosis leading to functional consequences needs to be higher
(Gottwald et al., 1997; Dhein and Hammerath, 2001). Moreover,
from the literature we assumed an antifibrotic effect of Ang(1-7)
overexpression, which-according to Figure 4B-could not be seen
in our model. Accordingly, we also did not observe significant
effects of Ang(1-7) on ventricular conduction spreading.
Regarding acute effects of Ang(1-7) Neves et al. demonstrated
that Ang(1-7) dose-dependently (27–210 nmol L−1) diminished
coronary flow in isolated-perfused rat hearts, without any
changes in inotropy or heart rate (Neves et al., 1997). Kumagai
et al. observed similar results in isolated hamster hearts (Kumagai
et al., 1990). Furthermore, in their study Nerves et al. showed
an Ang(1-7)-induced enhancement of reperfusion arrhythmias
in isolated-perfused rat hearts (Neves et al., 1997).
One may suggest that possibly the in vivo application of
dobutamine might have altered the intracellular calcium balance
affecting the isolated heart experiment. However, dobutamine
has a short half-life and the pre-dobutamine steady state values
were reached already during the in vivo experiment.
Several studies exist, revealing a cardioprotective role of ACE2
and Ang(1-7) (Ferreira et al., 2001; Pei et al., 2010; Johnson
et al., 2011; Dong et al., 2012; Feng et al., 2012; McCollum et al.,
2012). In contrast to the above mentioned proarrhythmic effect
of high Ang(1-7) concentrations, Ferreira et al. detected reduced
cardiac arrhythmias induced by ischemia/reperfusion associated
with low dose Ang(1-7) if acutely administered (Ferreira et al.,
2001). Similar to these observations, De Mello et al. described an
acute antiarrhythmic action of Ang(1-7) at low concentrations
(10−8 mol L−1), and a proarrhythmic effect of Ang(1-7) at higher
concentrations (10−7 mol L−1) in ventricular preparations of
cardiomyopathic hamsters (De Mello et al., 2007).
This biphasic effect of Ang(1-7) is also confirmed by
investigations of Sampaio et al., who showed that Wistar rats
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exhibited an altered regional blood flow distribution, an increase
in cardiac output and a reduced total peripheral resistance after
acute infusion of low dose of Ang(1-7) (110 fmolmin−1 10min−1
iv), whereas opposite effects could be observed after infusion of
high dose of Ang(1-7) (11 pmol min−1 10min−1 iv) (Sampaio
et al., 2003). However, this again refers to acute and not to chronic
effects.
In their study Ferreira et al. observed no differences in heart
rate and blood pressure between transgenic rats, overexpressing
Ang(1-7) and control rats (Ferreira et al., 2010). Similar to our
findings, there was a decrease in coronary flow in transgenic
rats. In contrast to the present study, Ferreira et al. showed
an improved cardiac function, indicated by elevated dp/dt and-
dp/dt and furthermore, an attenuation of the isoproterenol-
induced cardiac fibrosis in transgenic rats. Previous studies
also indicated an antifibrotic action of Ang(1-7) in vitro and
in vivo (Santos et al., 2004; Ferreira et al., 2010; Dong et al.,
2012; McCollum et al., 2012; Acuña et al., 2014). In contrast
to these findings, the present study revealed no antifibrotic
effect of Ang(1-7) in a transgenic rat model. Moreover, the
CD-induced myocardial fibrosis could not be prevented by an
overexpression of Ang(1-7). In their study Ferreira et al. used a
transgenic rat model, which expressed an Ang(1-7)-producing
fusion protein, specifically in the heart, which resulted in a
cardiac overexpression of Ang(1-7), whereas the plasma Ang(1-
7) concentration remained unchanged (Ferreira et al., 2010). In
contrast, our transgenic rat model was generated by an Ang(1-
7)-producing fusion protein, expressed in testis, which led to
an increase in circulating Ang(1-7) levels (Santos et al., 2004;
Schuchard et al., 2015). Thus, the findings of Ferreira et al.
seemed to be due to local production of cardiac Ang(1-7),
whereas our results were rather caused by systemic alterations.
Santos et al. (2004) measured Ang(1-7) in the same model as
we used, demonstrating elevated Ang(1-7) plasma concentration,
but unaltered tissue levels, which may be a result of the
short half-life of Ang(1-7), which is about 10 s (Yamada et al.,
1998).
Although, other working groups also used the same transgenic
rat model as described in the present study there are varying
results regarding cardiac function. These working groups
described an antiarrhythmic effect, attenuation of hypertension,
and a reduction of isoproterenol-induced myocardial fibrosis
and cardiac hypertrophy (Santos et al., 2004; Nadu et al.,
2008; Santiago et al., 2010). It should be noted, that Santiago
et al. only found beneficial effects of Ang(1-7) in rats after
deoxycorticosterone acetate (DOCA) salt-induced hypertension,
resulting in cardiac dysfunction and remodeling. Moreover, in
normotensive transgenic rats there was no cardioprotective effect
of Ang(1-7). Interestingly, Santiago et al. described elevated
plasma Ang(1-7) levels in normotensive transgenic rats, whereas
Ang(1-7) level in the left ventricle remained unchanged in
comparison to normotensive non-transgenic animals. Only after
induction of DOCA salt hypertension rats exhibited increased
left ventricular Ang(1-7). Moreover, evaluation of AngII, Mas
and AT1 receptor indicated no alteration in mRNA expression
in normotensive transgenic rats compared to normotensive
non-transgenic rats. In accordance with these findings, Santos
et al. demonstrated that the transgene expression in the TGR(A1-
7)3293 line is restricted to the testis, leading to an about 4.5-
fold increase in Ang(1-7) levels in testis as well as an elevation
of venous and arterial Ang(1-7) plasma concentrations, whereas
Ang(1-7) level in atrium and the left ventricle was unaltered
(Santos et al., 2004). These observations suggest that Ang(1-
7) may only exert cardioprotective effects under pathological
situations i.e., in the presence of an impaired cardiac function.
A balance between Ang(1-7) and AngII levels seems to prevent
any beneficial action of Ang(1-7) under physiological conditions.
This assumption is confirmed by a study of Mercure et al., who
showed that a chronic overproduction of cardiac Ang(1-7) in
mice did not affect heart function under normal hemodynamic
conditions (Mercure et al., 2008). Regarding heart function, it is
known that Ang(1-7) can mitigate isoprenaline effects (Martins
Lima et al., 2013), but has no effect on intracellular calcium
handling (Dias-Peixoto et al., 2008; Zhou et al., 2015) in normal
cardiomyocytes.
In our rat model we also did not observe cardiac dysfunction
after high-sugar diet, which could explain the absence of a
protective role of the heptapeptide in the heart.
LIMITATION
Commonly, obesity results in the development of
cardiometabolic disorders in the aging population. The rats
used in these experiments were 3 month old when we started
with the cafeteria diet and at an age of 8 month cardiac
measurements were performed. Thus, future studies with older
rats, receiving a longer diet, are needed to investigate whether
longer exposition to CD may lead to functionally relevant
cardiac fibrosis. Furthermore, we used a transgenic rat model,
which expressed an Ang(1-7)-producing fusion protein in testis,
leading to an overexpression of testicular and plasma Ang(1-7).
Thus, our findings regarding cardiac performance and structure
are ascribed to the action of systemic production of Ang(1-7)
rather than a local production of Ang(1-7) in the heart.
CLINICAL PERSPECTIVE
Previous studies demonstrated that inhibition of the
ACE/AngII/AT1 receptor axis attenuate metabolic abnormalities,
indicating the ACE/AngII/AT1 receptor arm as a therapeutic
strategy for the treatment of metabolic diseases (Feltenberger
et al., 2013; Santos et al., 2013a,b; Santos and Simoes, 2014).
Furthermore, there is evidence suggesting the ACE2/Ang(1-
7)/Mas receptor axis as a physiological antagonist of the
conventional ACE/AngII/AT1 receptor arm (Patel et al.,
2014).
Therefore, we wanted to investigate the effect of a high-sugar
diet and an overexpression of Ang(1-7) on cardiac performance
and remodeling in an experimental rat model of obesity.
Our results indicate that an overexpression of circulating
Ang(1-7) protects rats against a CD-induced increase in body
weight, but does not affect heart function. An overexpression of
Ang(1-7) alone led to an impaired cardiac performance.
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Due to its observed antiobese effect Ang(1-7) seems to be a
potential therapeutic option in treating obesity. This could be
relevant for human obesity, which may cause metabolic as well
as cardiovascular diseases in the long term. However, although
we did observe clear anti-obesity effects of Ang(1-7) we could
not confirm any cardioprotective effect. Even in contrast, the
cardiac performance was lower in the transgenics. Thus, from
our point of view it is too early to state, that Ang(1-7) may be the
pathway of choice to treat cardiovascular aspects of the metabolic
syndrome.
AUTHOR CONTRIBUTIONS
SD, FS, KB, AS, WR, MB, and ID conceived and designed the
experiments for this manuscript. SD, FS, KB, AS performed
the experiments, analyzed and interpreted the data of this
work. Transgenic rats were generated by MB. We received all
investigated rats fromWR.
ACKNOWLEDGMENTS
We acknowledge support from the German Research Foundation
(DFG) and Universität Leipzig within the program of Open
Access Publishing.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphys.
2015.00392
REFERENCES
Acuña, M. J., Pessina, P., Olguin, H., Cabrera, D., Vio, C. P., Bader, M., et al.
(2014). Restoration of muscle strength in dystrophic muscle by angiotensin-
1-7 through inhibition of TGF-β signalling. Hum. Mol. Genet. 23, 1237–1249.
doi: 10.1093/hmg/ddt514
Coatmellec-Taglioni, G., Dausse, J. P., Ribière, C., and Giudicelli, Y. (2000).
Hypertension in cafeteria-fed rats: alterations in renal alpha2-adrenoceptor
subtypes. Am. J. Hypertens. 13(5 Pt 1), 529–534. doi: 10.1016/S0895-
7061(99)00234-4
DeMello, W. C., Ferrario, C. M., and Jessup, J. A. (2007). Beneficial versus harmful
effects of Angiotensin (17) on impulse propagation and cardiac arrhythmias
in the failing heart. J. Renin Angiotensin Aldosterone Syst. 8, 74–80. doi:
10.3317/jraas.2007.015
Dhein, S., and Hammerath, S. B. (2001). Aspects of the intercellular
communication in aged hearts: effects of the gap junction uncoupler
palmitoleic acid. Naunyn Schmiedebergs. Arch. Pharmacol. 364, 397–408. doi:
10.1007/s002100100462
Dhein, S., Müller, A., Gerwin, R., and Klaus, W. (1993). Comparative study on the
proarrhythmic effects of some antiarrhythmic agents. Circulation 87, 617–630.
doi: 10.1161/01.CIR.87.2.617
Dias-Peixoto, M. F., Santos, R. A., Gomes, E. R., Alves, M. N., Almeida, P. W.,
Greco, L., et al. (2008). Molecular mechanisms involved in the angiotensin-(1-
7)/Mas signaling pathway in cardiomyocytes. Hypertension 52, 542–548. doi:
10.1161/HYPERTENSIONAHA.108.114280
Dong, B., Yu, Q. T., Dai, H. Y., Gao, Y. Y., Zhou, Z. L., Zhang, L., et al. (2012).
Angiotensin-converting enzyme-2 overexpression improves left ventricular
remodeling and function in a rat model of diabetic cardiomyopathy. J. Am. Coll.
Cardiol. 59, 739–747. doi: 10.1016/j.jacc.2011.09.071
Donoghue, M., Wakimoto, H., Maguire, C. T., Acton, S., Hales, P., Stagliano,
N., et al. (2003). Heart block, ventricular tachycardia, and sudden death in
ACE2 transgenic mice with downregulated connexins. J. Mol. Cell. Cardiol. 35,
1043–1053. doi: 10.1016/S0022-2828(03)00177-9
Durrer, D., and van der Tweel, L. H. (1954). Spread of activation in the left
ventricular wall of dog. II. Activation conditions at the epicardial surface. Am.
Heart J. 47, 192–203. doi: 10.1016/0002-8703(54)90249-5
Feltenberger, J. D., Andrade, J. M., Paraíso, A., Barros, L. O., Filho, A.
B., Sinisterra, R. D., et al. (2013). Oral formulation of angiotensin-(1-
7) improves lipid metabolism and prevents high-fat diet-induced hepatic
steatosis and inflammation in mice. Hypertension 62, 324–330. doi:
10.1161/HYPERTENSIONAHA.111.00919
Feng, Y., Hans, C., McIlwain, E., Varner, K. J., and Lazartigues, E. (2012).
Angiotensin-converting enzyme 2 over-expression in the central nervous
system reduces angiotensin-II-mediated cardiac hypertrophy. PLoS ONE
7:e48910. doi: 10.1371/journal.pone.0048910
Ferreira, A. J., Castro, C. H., Guatimosim, S., Almeida, P. W., Gomes, E.
R., Dias-Peixoto, M. F., et al. (2010). Attenuation of isoproterenol-induced
cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing
fusion protein in the heart. Ther. Adv. Cardiovasc. Dis. 4, 83–96. doi:
10.1177/1753944709353426
Ferreira, A. J., Santos, R. A., and Almeida, A. P. (2001). Angiotensin-(1-7):
cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38(3
Pt 2), 665–668. doi: 10.1161/01.HYP.38.3.665
Gottwald, M., Gottwald, E., and Dhein, S. (1997). Age-related
electrophysiological and histological changes in rabbit hearts: age-related
changes in electrophysiology. Int. J. Cardiol. 62, 97–106. doi:
10.1016/S0167-5273(97)00183-6
Gupte, M., Boustany-Kari, C. M., Bharadwaj, K., Police, S., Thatcher, S., Gong, M.
C., et al. (2008). ACE2 is expressed in mouse adipocytes and regulated by a
high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R781–R788. doi:
10.1152/ajpregu.00183.2008
Johnson, J. A., West, J., Maynard, K. B., and Hemnes, A. R. (2011). ACE2 improves
right ventricular function in a pressure overload model. PLoS ONE 6:e20828.
doi: 10.1371/journal.pone.0020828
Kumagai, H., Khosla, M., Ferrario, C., and Fouad-Tarazi, F. M. (1990). Biological
activity of angiotensin-(1-7) heptapeptide in the hamster heart. Hypertension
15(2 Suppl), I-29–I-33. doi: 10.1161/01.hyp.15.2_suppl.i29
Lutz, T. A., and Woods, S. C. (2012). Overview of animal models of obesity. Curr.
Protoc. Pharmacol. Chapter 5:Unit5.61. doi: 10.1002/0471141755.ph0561s58
Martins Lima, A., Xavier, C. H., Ferreira, A. J., Raizada, M. K., Wallukat,
G., Velloso, E. P., et al. (2013). Activation of angiotensin-converting
enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute
emotional stress. Am. J. Physiol. Heart Circ. Physiol. 305, H1057–H1067. doi:
10.1152/ajpheart.00433.2013
McCollum, L. T., Gallagher, P. E., and Tallant, E. A. (2012). Angiotensin-(1–7)
abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides 34,
380–388. doi: 10.1016/j.peptides.2012.01.020
Mercure, C., Yogi, A., Callera, G. E., Aranha, A. B., Bader, M., Ferreira,
A. J., et al. (2008). Angiotensin(1-7) blunts hypertensive cardiac
remodeling by a direct effect on the heart. Circ. Res. 103, 1319–1326. doi:
10.1161/CIRCRESAHA.108.184911
Miesel, A., Müller, H., Thermann, M., Heidbreder, M., Dominiak, P., and Raasch,
W. (2010). Overfeeding induced obesity in spontaneously hypertensive rats:
an animal model of the human metabolic syndrome. Ann. Nutr. Metab. 56,
127–142. doi: 10.1159/000278748
Müller-Fielitz, H., Hübel, N., Mildner, M., Vogt, F. M., Barkhausen, J., and
Raasch, W. (2014). Chronic blockade of angiotensin AT1 receptors
improves cardinal symptoms of metabolic syndrome in diet- induced
obesity in rats. Br. J. Pharmacol. 171, 746–760. doi: 10.1111/bph.
12510
Müller-Fielitz, H., Lau, M., Geißler, C., Werner, L., Winkler, M., and Raasch, W.
(2015). Preventing leptin resistance by blocking angiotensin II AT1 receptors
in diet-induced obese rats. Br. J. Pharmacol. 172, 857–868. doi: 10.1111/bph.
12949
Frontiers in Physiology | www.frontiersin.org 10 December 2015 | Volume 6 | Article 392
Blanke et al. Angiotensin(1-7) and Heart Function
Muntzel, M. S., Al-Naimi, O. A., Barclay, A., and Ajasin, D. (2012).
Cafeteria diet increases fat mass and chronically elevates lumbar
sympathetic nerve activity in rats. Hypertension 60, 1498–1502. doi:
10.1161/HYPERTENSIONAHA.112.194886
Nadu, A. P., Ferreira, A. J., Reudelhuber, T. L., Bader, M., and Santos, R. A. (2008).
Reduced isoproterenol-induced renin-angiotensin changes and extracellular
matrix deposition in hearts of TGR(A1-7)3292 rats. J. Am. Soc. Hypertens. 2,
341–348. doi: 10.1016/j.jash.2008.04.012
Neves, L. A. A., Almeida, A. P., Khosla, M. C., Campagnole-Santos, M. J., and
Santos, R. A. S. (1997). Effect of angiotensin-(1-7) on reperfusion arrhythmias
in isolated rat hearts. Braz. J. Med. Biol. Res. 30, 801–809. doi: 10.1590/S0100-
879X1997000600016
Passos-Silva, D. G., Verano-Braga, T., and Santos, R. A. (2013). Angiotensin-
(1-7): beyond the cardio-renal actions. Clin. Sci. 124, 443–456. doi:
10.1042/CS20120461
Patel, V. B., Parajuli, N., and Oudit, G. Y. (2014). Role of angiotensin-converting
enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin. Sci. 126,
471–482. doi: 10.1042/CS20130344
Pei, Z., Meng, R., Li, G., Yan, G., Xu, C., Zhuang, Z., et al. (2010). Angiotensin-(1–7)
ameliorates myocardial remodeling and interstitial fibrosis in spontaneous
hypertension: role of MMPs/TIMPs. Toxicol. Lett. 199, 173–181. doi:
10.1016/j.toxlet.2010.08.021
Sampaio,W.O., Nascimento, A. A., and Santos, R. A. (2003). Systemic and regional
hemodynamic effects of angiotensin-(1-7) in rats. Am. J. Physiol. Heart Circ.
Physiol. 284, H1985–H1994. doi: 10.1152/ajpheart.01145.2002
Santiago, N. M., Guimarães, P. S., Sirvente, R. A., Oliveira, L. A., Irigoyen,
M. C., Santos, R. A., et al. (2010). Lifetime overproduction of circulating
Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-
induced cardiac dysfunction and remodeling. Hypertension 55, 889–889. doi:
10.1161/HYPERTENSIONAHA.110.149815
Santos, R. A. (2014). Angiotensin-(1-7). Hypertension 63, 1138–1147. doi:
10.1161/HYPERTENSIONAHA.113.01274
Santos, R. A., Ferreira, A. J., Pinheiro, S. V., Sampaio, W. O., Touyz, R., and
Campagnole-Santos, M. J. (2005). Angiotensin-(1-7) and its receptor as a
potential targets for new cardiovascular drugs. Expert Opin. Investig. Drugs 14,
1019–1031. doi: 10.1517/13543784.14.8.1019
Santos, R. A., Ferreira, A. J., Verano-Braga, T., and Bader,M. (2013a). Angiotensin-
converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-
angiotensin system. J. Endocrinol. 216, R1–R17. doi: 10.1530/JOE-12-0341
Santos, R. A. S., Ferreira, A. J., Nadu, A. P., Braga, A. N., de Almeida, A. P.,
Campagnole-Santos, M. J., et al. (2004). Expression of an angiotensin- (1-
7)- producing fusion protein produces cardioprotective effects in rats. Physiol.
Genomics 17, 292–299. doi: 10.1152/physiolgenomics.00227.2003
Santos, S. H., Andrade, J. M., Fernandes, L. R., Sinisterra, R. D., Sousa, F. B.,
Feltenberger, J. D., et al. (2013b). Oral Angiotensin-(1-7) prevented obesity and
hepatic inflammationby inhibition of resistin/TLR4/MAPK/NF-kappaB in rats
fed with high-fat diet. Peptides 46, 47–52. doi: 10.1016/j.peptides.2013.05.010
Santos, S. H., Braga, J. F., Mario, E. G., Pôrto, L. C., Rodrigues-Machado Mda, G.,
Murari, A., et al. (2010). Improved lipid and glucose metabolism in transgenic
rats with increased circulating angiotensin-(1-7). Arterioscler. Thromb. Vasc.
Biol. 30, 953–961. doi: 10.1161/ATVBAHA.109.200493
Santos, S. H., Fernandes, L. R., Mario, E. G., Ferreira, A. V., Pôrto, L. C.,
Alvarez-Leite, J. I., et al. (2008). Mas deficiency in FVB/N mice produces
marked changes in lipid and glycemic metabolism. Diabetes 57, 340–347. doi:
10.2337/db07-0953
Santos, S. H., Fernandes, L. R., Pereira, C. S., Guimarães, A. L., de Paula,
A. M., Campagnole-Santos, M. J., et al. (2012). Increased circulating
angiotensin-(1-7) protects white adipose tissue against development of a
proinflammatory state stimulated by a high-fat diet. Regul. Pept. 178, 64–70.
doi: 10.1016/j.regpep.2012.06.009
Santos, S. H., and Simões, E. S. A. C. (2014). The therapeutic role of Renin-
Angiotensin system blockers in obesity-related renal disorders. Curr. Clin.
Pharmacol. 9, 2–9. doi: 10.2174/15748847112079990050
Schuchard, J., Winkler, M., Stölting, I., Schuster, F., Vogt, F. M., Barkhausen, J.,
et al. (2015). Lack of weight gain after angiotensin AT1 receptor blockade
in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-
dependent pathway. Br. J. Pharmacol. 172, 3764–3778. doi: 10.1111/bph.
13172
Steiner, M. A., Sciarretta, C., Pasquali, A., and Jenck, F. (2013). The selective
orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced
obesity associated with metabolic syndrome. Front. Pharmacol. 4:165. doi:
10.3389/fphar.2013.00165
Yamada, K., Iyer, S. N., Chappell, M. C., Ganten, D., and Ferrario, C. M.
(1998). Converting enzyme determines plasma clearance of angiotensin-(1-7).
Hypertension 32, 496–502. doi: 10.1161/01.HYP.32.3.496
Zhou, P., Cheng, C. P., Li, T., Ferrario, C. M., and Cheng, H. J. (2015). Modulation
of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart
failure. Ther. Adv. Cardiovasc. Dis. 9, 342–353. doi: 10.1177/1753944715587424
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Blanke, Schlegel, Raasch, Bader, Dähnert, Dhein and Salameh.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 11 December 2015 | Volume 6 | Article 392
